Teva Pharmaceutical Industries Limited

TEVA·NYSE·Healthcare
Compare
41.85−0.06 (−0.14%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market41.55−0.27 (−0.65%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close41.91
Open41.89
Day range41.2942.59
52-week range23.6143.34
Off day high−1.74%
Off 52-week high−3.44%
Volume10.03M
Avg. volume (3M)5.79M
Market cap48.83B
EPS (TTM)0.4300
Forward P/E13.44
P/E ratio (TTM)97.33
Dividend yield—
Beta (5Y)—
Shares outstanding1.17B
Short interest2.42% of float
Earnings dateNov 3, 2026 (est.)
Analyst target48.94
Profit margin2.94%

Against its peers

Compare in full ›
TEVA 1795.TW IOLCP.BO TAK JUBLPHARMA.BO VTRS
Market cap 48.83B 44.76B 55.54B 67.28B 150.00B 22.08B
P/E (TTM) 97.3 11.8 27.3 300.9 42.7 —
Forward P/E 13.4 7.1 17.5 39.7 18.7 7.1
Price/book 6.1 1.9 2.9 1.4 2.1 1.6
Dividend yield — 1.61% 0.54% 2.93% 0.53% 2.49%
1-year change +71.10% −42.88% +102.42% +54.40% −19.11% +90.11%
Today −0.14% +5.66% +3.08% +1.49% +0.79% +1.59%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Related companies

Compare ›

What visitors to Teva Pharmaceutical Industries's page also look at.

Company Mkt cap Price Today
Gilead Sciences, Inc.GILDOdds 216.41B 174.48 +4.19%
Biogen Inc.BIIB 37.61B 254.46 +2.22%
Bristol-Myers Squibb CompanyBMY 131.21B 64.19 +4.02%
Novartis AGNVS 311.59B 164.98 +3.59%
GSK plcGSK 102.53B 51.15 +5.03%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All TEVA news ›
ynetglobal·Positive

Teva expands US drug portfolio in Samsung Bioepis deal

Israeli drugmaker secures commercialization rights to two FDA-approved treatments for chronic inflammatory diseases, expanding its partnership with the South Korean company; financial terms were not disclosed Israeli drugmaker Teva…

TEVA
Grafa·Positive

Teva signs deal for two FDA-approved biosimilars

Assets related to this article Teva will obtain ETICOVO commercialization rights at closing and infliximab-abda rights in the third quarter of 2027, while Samsung Bioepis retains manufacturing and regulatory oversight. The transaction is…

TEVA
92.7 FM WHTC | Holland·Positive

Teva Pharmaceutical Q3 profit gain beats estimates

JERUSALEM, Nov 3 (Reuters) – Israeli drugmaker Teva Pharmaceutical Industries, reported on Tuesday a ​higher-than-expected rise in third-quarter ‌profit, helped by strong sales of a trio of its own drugs to offset declines ‌in ​copycat…

TEVABCS

From the 4Search news index, newest first.

In the news

47mentions in 30 days
9with it in the headline
Positivesentiment

Mentioned with

Dual Action Rescue Inhaler38AC Immune35Eli Lilly16Novo Nordisk15Teva Pharmaceutical Industries Ltd.14U.S. Food and Drug Administration14Pfizer13Teva Pharmaceutical13

People in the coverage

Kinjel Shah42Amarin41Michael Walen27Austedo21Sarita Garza19Richard Francis18

Themes

Healthcare26Sny23FDA13Financial13Aciu10Pharmaceuticals10Finanzen9Amrn8

Most coverage from

  1. markets.businessinsider.com7
  2. tradingview.com7
  3. seekingalpha.com4
  4. gurufocus.com3
  5. fool.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 47 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance